Literature DB >> 12792735

Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.

Kanae Yamada1, Xiaoling Zhong, Shinsaku Kanazawa, Junichi Koike, Kazunori Tsujita, Hiromichi Hemmi.   

Abstract

The deficiency of the DNA mismatch repair (MMR) system is involved in tumorigenesis of either familial or sporadic colorectal cancers showing microsatellite instability (MSI). To investigate the involvement of the mutated hMSH2 gene in carcinogenesis, we searched for alteration of the gene in 15 MSI tumors of Japanese patients with sporadic colorectal cancer by a polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) and DNA sequencing analyses. We found 20 alterations including 7 novel mutations, 6 germline and one somatic. To assume an oncogenic pathway of tumor of two patients carrying germline missense mutations, G40S located in an evolutionarily conserved amino-terminal motif and Y619C in a domain interacting with either hMSH3 or hMSH6, somatic mutations in 9 target genes of the MMR defect and in the p53 and K-ras genes and loss of heterozygosity (LOH) at the hMLH1 and p53 gene loci were then studied. In the tumor carrying G40S, other somatic hMSH2 mutations, G203R and 687delA in the (A)(7) repeat, and 5 one-bp deletions in the target genes were found, while no mutation in the p53 and K-ras genes. These results indicate that G40S may affect the hMSH2 function and the tumor may be developed by a typical MSI pathway. In another tumor with Y619C, LOH at the hMLH1 gene locus, no mutation in MMR target genes, and two-hit inactivation of the p53 gene were detected. This MSI tumor seems to be developed by another than MSI pathway. These results indicate that there are different oncogenic pathways in the MSI sporadic colorectal cancers with germline missense mutations in the hMSH2 gene. We conclude that familial colorectal cancer-suspected cases exist in a small population of sporadic colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792735

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells.

Authors:  Abhijit Rath; Akriti Mishra; Victoria Duque Ferreira; Chaoran Hu; Gregory Omerza; Kevin Kelly; Andrew Hesse; Honey V Reddi; James P Grady; Christopher D Heinen
Journal:  Hum Mutat       Date:  2019-08-17       Impact factor: 4.878

2.  Down-regulation of MutS homolog 3 by hypoxia in human colorectal cancer.

Authors:  Jie Li; Junichi Koike; Hiroyuki Kugoh; Michitsune Arita; Takahito Ohhira; Yoshinori Kikuchi; Kimihiko Funahashi; Ken Takamatsu; C Richard Boland; Minoru Koi; Hiromichi Hemmi
Journal:  Biochim Biophys Acta       Date:  2012-02-09

3.  Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India.

Authors:  Pooja Malhotra; Mumtaz Anwar; Rakesh Kochhar; Shabeer Ahmad; Kim Vaiphei; Safrun Mahmood
Journal:  Tumour Biol       Date:  2013-12-10

4.  Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.

Authors:  Kanae Yamada; Shinsaku Kanazawa; Junichi Koike; Hisahiko Sugiyama; Can Xu; Kimihiko Funahashi; C Richard Boland; Minoru Koi; Hiromichi Hemmi
Journal:  Oncol Rep       Date:  2010-02       Impact factor: 3.906

5.  Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.

Authors:  Fulan Hu; Dandan Li; Yibaina Wang; Xiaoping Yao; Wencui Zhang; Jing Liang; Chunqing Lin; Jiaojiao Ren; Lin Zhu; Zhiwei Wu; Shuying Li; Ye Li; Xiaojuan Zhao; Binbin Cui; Xinshu Dong; Suli Tian; Yashuang Zhao
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.